Author Archives: admin

Reimbursement Issues Cited as Central Challenge in Physician Salary Survey – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Reimbursement Issues Cited as Central Challenge in Physician Salary Survey – APhA submits compounding comments to FDA. – (866) 348-2889. For 2018, salaries were either flat or declined for most physicians. The … Continue reading

Posted in Pharmacist | Tagged , , , | Leave a comment

FDA Approves Pembrolizumab Combo Therapy for Advanced Renal Cell Carcinoma – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Approves Pembrolizumab Combo Therapy for Advanced Renal Cell Carcinoma – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Pembrolizumab (Keytruda, Merck) has received FDA approval as a … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Grants Final Approval for First Generic Naloxone Nasal Spray – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Grants Final Approval for First Generic Naloxone Nasal Spray – APhA submits compounding comments to FDA. – (866) 348-2889. Officials with the FDA have granted final approval to the first generic … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Pharmacy Times Wants Your Opinions – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Pharmacy Times Wants Your Opinions – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 The editors of Pharmacy Times would like to know your opinions on content for … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Robust Responses Found in 20-Serotype Pneumococcal Vaccine Trial – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Robust Responses Found in 20-Serotype Pneumococcal Vaccine Trial – APhA submits compounding comments to FDA. – (866) 348-2889. The FDA granted Breakthrough Therapy Designation for a 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) in … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

ASHP Offering Sterile Product Preparation Certificate Program – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF ASHP Offering Sterile Product Preparation Certificate Program – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 The American Society of Health-Systems Pharmacists (ASHP) has launched a new Sterile … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

New Treatment for Osteoporosis In Postmenopausal Women is Available – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF New Treatment for Osteoporosis In Postmenopausal Women is Available – APhA submits compounding comments to FDA. – (866) 348-2889. Amgen’s romosozumab-aqqg therapy (Evenity) for osteoporosis in postmenopausal women is now available for … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Manufacturer to Produce Cell-Based Flu Vaccine for Next Season – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Manufacturer to Produce Cell-Based Flu Vaccine for Next Season – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Influenza protection company Seqirus has announced the filing of an … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA OKs Prescription Weight Management Therapy – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA OKs Prescription Weight Management Therapy – APhA submits compounding comments to FDA. – (866) 348-2889. Officials with the US Food and Drug Administration have approved a therapy, Plenity, by PureTech Health … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

First Targeted Therapy for Metastatic Bladder Cancer Receives FDA Approval – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF First Targeted Therapy for Metastatic Bladder Cancer Receives FDA Approval – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Official with the FDA today granted accelerated approval to … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off